A

Aspen Pharmacare Holdings Ltd
JSE:APN

Watchlist Manager
Aspen Pharmacare Holdings Ltd
JSE:APN
Watchlist
Price: 11 384 Zac -0.58% Market Closed
Market Cap: 50.7B Zac

Profitability Summary

Aspen Pharmacare Holdings Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Aspen Pharmacare Holdings Ltd

Revenue
43.4B ZAR
Cost of Revenue
-24.2B ZAR
Gross Profit
19.1B ZAR
Operating Expenses
-17.7B ZAR
Operating Income
1.4B ZAR
Other Expenses
-2.5B ZAR
Net Income
-1.1B ZAR

Margins Comparison
Aspen Pharmacare Holdings Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
50.7B Zac
44%
3%
-3%
US
Eli Lilly and Co
NYSE:LLY
1T USD
83%
44%
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
US
Johnson & Johnson
NYSE:JNJ
499.3B USD
68%
27%
27%
CH
Roche Holding AG
SIX:ROG
269.3B CHF
74%
34%
15%
UK
AstraZeneca PLC
LSE:AZN
220.6B GBP
82%
24%
16%
US
Merck & Co Inc
NYSE:MRK
270.1B USD
79%
38%
30%
CH
Novartis AG
SIX:NOVN
218B CHF
76%
33%
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
82%
42%
33%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
68%
11%
-126%
US
Pfizer Inc
NYSE:PFE
143.7B USD
75%
29%
16%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Aspen Pharmacare Holdings Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
50.7B Zac
-1%
-1%
1%
11%
US
Eli Lilly and Co
NYSE:LLY
1T USD
97%
19%
42%
25%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
US
Johnson & Johnson
NYSE:JNJ
499.3B USD
33%
13%
18%
13%
CH
Roche Holding AG
SIX:ROG
269.3B CHF
33%
10%
31%
19%
UK
AstraZeneca PLC
LSE:AZN
220.6B GBP
22%
9%
18%
15%
US
Merck & Co Inc
NYSE:MRK
270.1B USD
40%
15%
26%
21%
CH
Novartis AG
SIX:NOVN
218B CHF
33%
14%
25%
18%
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
71%
23%
57%
28%
IE
Endo International PLC
LSE:0Y5F
213.9B USD
70%
-51%
5%
6%
US
Pfizer Inc
NYSE:PFE
143.7B USD
11%
5%
11%
10%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less